Skip to main content
. 2006 Sep 25;103(40):14889–14894. doi: 10.1073/pnas.0604045103

Fig. 2.

Fig. 2.

pIRS21097–1105-, pβ-catenin30–39-, and pCDC25b38–46-specific CD8+ T lymphocytes recognize endogenously processed and presented phosphopeptides on the surface of cancer cell lines. (A) Recognition of C1RAAD stimulators pulsed with the indicated concentrations of synthetic phosphopeptide or its nonphosphorylated homolog by either pIRS21097–1105- or pCDC25b38–46-specific CD8+ T lymphocytes (Left) or pβ-catenin30–39-specific CD8+ T lymphocytes (Right). (B) Recognition of endogenously processed phosphopeptides on the indicated cell lines by pIRS21097–1105-, pβ-catenin30–39-, and pCDC25b38–46-specific CD8+ T cells.